Embracing Change: The Impact of Scilex Holding Company’s Recent Announcement Introduction As news of Scilex Holding Company’s recent announcement spreads, it’s clear that change is on the horizon for both the company and its stakeholders. With Sorrento Therapeutics, Inc. as the majority stockholder, the implications of this decision extend far beyond just a simple dividend…

Oak Ridge Financial Services, Inc. Announces Fourth Quarter and Full Year 2022 Results and Quarterly Cash Dividend of $0.08 per share Oak Ridge, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) Oak Ridge Financial Services, Inc. (“Oak Ridge”; or the “Company”) (OTCPink: BKOR), the parent company of Bank of Oak Ridge (the “Bank”), announced unaudited financial results…

Company Financial Tradition Reports 89% Increase in Q4 2022 Revenue Description: Compagnie Financière Tradition (CFT), a Swiss interdealer broker and operator of a Japanese retail broking giant, reported the consolidated revenue as CHF 231.1 for the fourth quarter of 2022. The figure jumped from CHF 219 million generated in the last three months of the…

A Rise in Respiratory Diseases Sparks Growth in Wearable Pulse Oximeters Market Wilmington, Delaware, United States, Feb. 02, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The global Wearable Pulse Oximeters Market is likely to register a CAGR of 7.0% between 2022 and 2031. With the rise in the prevalence of respiratory diseases, the…

Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering Embracing Growth and Innovation Integer Holdings Corporation, a leading medical device outsource manufacturer, has recently made a significant announcement that is poised to impact the financial landscape. The Company revealed that it has priced an offering of $435 million aggregate principal amount of 2.125%…

Biosynex and Chembio Diagnostics Announce Definitive Agreement to Merge Complementary Technologies and Market Opportunities Drive Merger In a move expected to shake up the medical diagnostics industry, Biosynex SA and Chembio Diagnostics have announced a definitive agreement to merge. The merger will combine Biosynex’s expertise in the design and distribution of rapid tests with Chembio…

LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Faster Diagnosis and Treatment Introduction Run on the highly portable LumiraDx Platform, the LumiraDx NT-proBNP test is a quantitative, fingerstick blood assay designed for near-patient testing with lab-comparable results in 12 minutes. It is the only fingerstick NT-proBNP test currently commercially…

Dallas Fed Manufacturing Index for January Overview The Dallas Fed manufacturing index for January came in at -8.4, a significant improvement from the previous month’s revised figure of -20. This indicates a less severe contraction in manufacturing activity in the region. Let’s take a closer look at some of the key components of the report:…